Scarica l'app Stockscreener
1.2201
0.01%
0.000100
Precedente Chiudi:
$1.22
Aprire:
$1.22
Volume 24 ore:
18,737
Relative Volume:
0.01
Capitalizzazione di mercato:
$11.56M
Reddito:
$5.64M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-2.3021
EPS:
-0.53
Flusso di cassa netto:
$-22.36M
1 W Prestazione:
-10.29%
1M Prestazione:
-5.42%
6M Prestazione:
-13.90%
1 anno Prestazione:
-69.34%
Intervallo 1D:
$1.2036
$1.24
Intervallo di 1 settimana:
$1.2036
$1.405
Portata 52W:
$0.95
$4.166
Evogene Ltd Stock (EVGN) Company Profile
Confronta EVGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.2212 | 11.56M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.41 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
601.00 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.42 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.07 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.09 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - ca.finance.yahoo.com
Evogene Ltd. Reports Improved Revenue Amidst Losses - TipRanks
Evogene Announces Q2 2025 Financial Results and Strategic Shift to AI - MSN
Evogene: Q2 Earnings Snapshot - Norwalk Hour
Evogene's Q2 2025: Unraveling Contradictions in Castor Seed Strategy and Financial Outlook - AInvest
Evogene Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene’s Q2 2025 results reveal significant cost cuts - Investing.com
Evogene Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Momentum Screeners Rank Evogene Ltd. in Top 5 TodayJuly 2025 Highlights & Proven Capital Preservation Methods - classian.co.kr
Evogene's Earnings Dilemma: A Cautionary Tale for Biotech Innovation - AInvest
Evogene Reports Second Quarter 2025 Financial Results - PR Newswire
Evogene Shareholders Approve Proposals at Annual Meeting - TipRanks
How does Evogene Ltd. correlate with Nasdaq2025 Earnings Impact & Free Safe Entry Trade Signal Reports - thegnnews.com
Heatmap analysis for Evogene Ltd. and competitors2025 Earnings Impact & Momentum Based Trading Ideas - Newser
Should you hold or exit Evogene Ltd. now2025 Retail Activity & Precise Swing Trade Entry Alerts - Newser
Can Evogene Ltd. rally from current levelsJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
Evogene (EVGN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Will Evogene Ltd. see short term momentumRate Cut & High Return Trade Opportunity Guides - Newser
Should you wait for a breakout in Evogene Ltd.Market Movement Recap & Entry Point Confirmation Signals - Newser
Can momentum traders help lift Evogene Ltd.2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
What MACD and RSI say about Evogene Ltd.CEO Change & Fast Momentum Stock Entry Tips - Newser
What risks could impact Evogene Ltd. stock performancePortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Identifying reversal signals in Evogene Ltd.July 2025 Volume & Daily Growth Stock Tips - Newser
Trend analysis for Evogene Ltd. this weekCEO Change & AI Driven Price Predictions - Newser
Visualizing Evogene Ltd. stock with heatmapsJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Can swing trading help recover from Evogene Ltd. lossesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on Evogene Ltd.Market Trend Summary & Reliable Entry Point Trade Alerts - Newser
Volume spikes in Evogene Ltd. stock – what they meanJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Momentum divergence signals in Evogene Ltd. chartEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Is Evogene Ltd. still worth holding after the dip2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Evogene Ltd. recovery potential after sell offJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Predicting Evogene Ltd. trend using moving averagesPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
Evogene Ltd. Matches Institutional Buying FilterTrade Ideas & Fast Entry High Yield Tips - kangso.co.kr
Evogene Ltd expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Evogene Ltd. stock daily chart insightsMarket Sentiment Review & Community Trade Idea Sharing - Newser
Applying chart zones and confluence areas to Evogene Ltd.July 2025 Intraday Action & Safe Entry Point Alerts - Newser
Evogene Ltd. Reaches Critical Trendline SupportJuly 2025 Macro Moves & Step-by-Step Swing Trade Plans - beatles.ru
Evogene (NASDAQ:EVGN) Upgraded at Alliance Global Partners - Defense World
Is Evogene Ltd. vulnerable to short sellers2025 Earnings Impact & Consistent Income Trade Ideas - thegnnews.com
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - StreetInsider
Is Evogene Ltd. likely to announce a buybackFast Money Trade Selections - 한국정경신문
Price Consolidation Hints at Upcoming Move in Evogene Ltd.Conservative Long Term Growth Plans Under Review - sundaytimes.kr
Evogene Ltd. and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - MarketScreener
Evogene partners with Tel Aviv University to develop metabolic disease treatments - Investing.com Nigeria
Evogene partners with Tel Aviv University to develop metabolic disease treatments By Investing.com - Investing.com South Africa
Evogene and Tel Aviv University collaborate on drug discovery for metabolite-related diseases. - AInvest
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases – Company AnnouncementFT.com - Financial Times
How Evogene Ltd. stock performs during market volatilityBuy and Hold Strategy for Capital Safety - Newser
Can Evogene Ltd. maintain sales growthSmart Entry for Explosive Returns - mustnews.co.kr
Has Evogene Ltd. Stock Ever Crashed Historical Volatility ReviewDownside Control Plan With Support Analysis - Newser
Trapped Investors in Evogene Ltd. Await Breakout SignalVerified Signal From Chart Patterns Detected - beatles.ru
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):